---
slug: semax-intro
title: Semax: Upregulating BDNF for Neuroprotection and Cognitive Recovery
canonical: https://miscsubjects.com/a/semax-intro
---

## BDNF Decline and Brain Health

BDNF production declines with age, stress, and neurotoxic exposure (mechanistic; no human data on Semax reversing this specifically).

## Semax Mechanism

Semax is described as upregulating BDNF for potential neuroprotection and cognitive effects.

### Preclinical Evidence (Rat and Cell Studies)

In rat basal forebrain, intranasal Semax increased BDNF protein levels after 3 hours (preclinical). [Source: Dolotov et al., 2006]

A single intranasal dose increased BDNF protein 1.4-fold, TrkB phosphorylation 1.6-fold, and BDNF mRNA 3-fold in rat hippocampus, with improved conditioned avoidance (preclinical). [Source: Dolotov et al., Brain Research 2006]

Semax increased BDNF mRNA up to 8-fold in murine glial cell cultures (preclinical).

### Human Data

One referenced study in 110 post-stroke patients reported Semax raised plasma BDNF levels correlating with recovery metrics (human, limited details available; no large-scale Western RCTs).

Pilot studies in healthy subjects noted EEG and attention changes (human, small scale).

No large human trials confirm BDNF upregulation or cognitive recovery endpoints in non-clinical populations.

## Evidence Gaps

Most data derive from rat models and cell cultures; human data remain preliminary and region-specific (stroke context in Russian literature).

---

Related:
[Semax](/a/semax)

[[embed:semax]]
